ARTICLE
Volume 10,Issue 4
30 November 2021
Research Progress of Anti-Tumor Angiogenesis in Traditional Chinese Medicine
Tao Gou ,
Hailong Si
Show Less
1
Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China,
2
The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China ,
PAR 2021 , 5(6), 30–33;
https://doi.org/10.26689/par.v5i6.2797
© 2021 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
In recent years, seeking effective anti-angiogenic components and therapeutic methods from traditional Chinese Medicine (TCM) has been a hot spot in the treatment of malignant tumors. In particular, the active ingredients found in Chinese herbal extracts have shown strong inhibition of tumor neovascularization.
References
Folkman J, 1971, Tumor Angiogenesis: Therapeutic Implications. The New England Journal of Medicine, 285(21): 1182-1186.
Folkman J, 1972, Anti-Angiogenesis: New Concept for Therapy of Solid Tumors. Annals of Surgery, 175(3): 409-416.
Dimova I, Popivanov G, Djonov V, 2014, Angiogenesis in Cancer – General Pathways and Their Therapeutic Implications. Journal of BUON: Official Journal of the Balkan Union of Oncology, 19(1): 15-21.
Ribatti D, Nico B, Crivellato E, et al., 2007, The History of the Angiogenic Switch Concept. Leukemia, 21(1): 44-52.
Dor Y, Porat R, Keshet E, 2001, Vascular Endothelial Growth Factor and Vascular Adjustments to Perturbations in Oxygen Homeostasis. American Journal of Physiology Cell Physiology, 280(6): 1367-1374.
Zhang T, Sun X, 2016, Mind and Brain Government Apirit: Understanding the Integration of Mind and Brain. Chinese Journal of Rehabilitation Theory and Practice, 22(003): 368-370.
Cheng H, 2014, Discussion on the Theory of Cancer Virus and Pathogenesis. Journal of Traditional Chinese Medicine, 55(20): 1711-1714.
Tie M, Zhang Y, 2014, Discussion on the Mechanism of Promoting Blood Circulation and Removing Stasis to Normalize Tumor Vessels. West China Medical Journal, (12): 2379-2381.
Zheng W, Yang X, Wu L, et al., 2007, Discussion on the Molecular Mechanism of Curcumin Against Angiogenesis. Chinese Journal of Clinical Oncology, 34(12): 683-685.
Gururaj AE, Belakavadi M, Venkatesh DA, et al., 2002, Molecular Mechanisms of Anti-Angiogenic Effect of Curcumin. Biochemical & Biophysical Research Communications, 297(4): 934-942.
Ortiz LM, Lombardi P, Tillhon M, et al., 2014, Berberine, an Epiphany Against Cancer. Molecules, 19(8): 12349-12367.
Jin F, Xie T, Huang X, et al., 2018, Berberine Inhibits Angiogenesis in Glioblastoma Xenografts by Targeting the VEGFR2/ERK Pathway. Pharmaceutical Biology, 56(1): 665-71.
Liu J, Zhang D, Chen M, et al., 2011, Inhibition of Angiogenesis by Arenobufagin. Acta Pharmaceutica Sinica, (05): 527-533.
Li M, Wu S, Liu Z, et al., 2012, Arenobufagin, a Bufadienolide Compound from Toad Venom, Inhibits Vegf-Mediated Angiogenesis Through Suppression of Vegfr-2 Signaling Pathway. Biochemical Pharmacology, 83(9): 1251-1260.
Lee DY, Yasuda M, Yamamoto T, et al., 1997, Bufalin Inhibits Endothelial Cell Proliferation and Angiogenesis In Vitro. Life Sciences, 60(2): 127-134.
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia